Research ArticleResearch

Herpes Simplex Virus-1 and Hand Sanitizer: A pilot study

Amanda L. Gibbs, Leciel K. Bono and JoAnn R. Gurenlian
American Dental Hygienists' Association August 2024, 98 (4) 28-36;

REFERENCES

  1. 1.↵
    1. National Institute of Dental and Craniofacial Research
    . Fever blisters and canker sores [Internet]. Bethesda: National Institute of Dental and Craniofacial Research; 2021 [cited 2024 Jan 26]. Available from: https://www.nidcr.nih.gov/health-info/fever-blisters-canker-sores
  2. 2.↵
    1. World Health Organization
    . Herpes simplex virus [Internet]. Geneva: World Health Organization; 2023 [cited 2024 Jan 26]. Available from: https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus
  3. 3.↵
    1. Auday BC,
    2. Buratovich MA,
    3. Marrocco MA, et al.
    1. Mahoney J.
    Cold sores. In: Auday BC, Buratovich MA, Marrocco MA, et al. editors. Magill’s medical guide. 7th ed. Hackensack (NJ): Salem Press. 2014. p. 506-507
  4. 4.↵
    1. Richardson VN,
    2. Davis SA,
    3. Gustafson CJ, et al.
    Patterns of disease and treatment of cold sores. J Dermatolog Treat. 2013 Dec;24(6):439-43.
    OpenUrl
  5. 5.↵
    1. Farooq AV,
    2. Shukla D.
    Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol. 2012 Sep;57(5):448-62.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Greenberg MS.
    Herpesvirus infections. Dent Clin North Am. 1996 Apr;40(2):359-68.
    OpenUrlPubMed
  7. 7.
    1. Sarid R,
    2. Klepfish A,
    3. Schattner A.
    Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). Mayo Clin Proc Digit Health. 2002 Sep;77(9): 941-49.
    OpenUrl
  8. 8.↵
    1. Szczubiałka K,
    2. Pyrć K,
    3. Nowakowska M.
    In search for effective and definitive treatment of herpes simplex virus type 1(HSV-1) infections. RSC Adv. 2016 Jan;6(6):1058-75.
    OpenUrlCrossRef
  9. 9.↵
    1. Duarte LF,
    2. Farías MA,
    3. Álvarez DM et al.
    Herpes simplex virus type 1 infection of the central nervous system: Insights into proposed interrelationships with neurodegenerative disorders. Front Synaptic Neurosci. 2019 Feb;13(46):1-23.
    OpenUrl
  10. 10.↵
    1. Taylor TJ,
    2. Brockman MA,
    3. McNamee EE, et al.
    Herpes simplex virus. Front Biosci. 2002 Mar;7(4):752-64.
    OpenUrlCrossRef
  11. 11.↵
    1. Quinn JP,
    2. Dalziel RG,
    3. Nash AA.
    Herpes virus latency in sensory ganglia—a comparison with endogenous neuronal gene expression. Prog Neurobiol. 2000 Feb;60(2):167-79.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Wisskirchen K,
    2. Lucifora J,
    3. Michler T, et al.
    New pharmacological strategies to fight enveloped viruses. Trends Pharmacol Sci. 2014 Sep;35(9): 470-78.
    OpenUrlCrossRef
  13. 13.↵
    1. Ramchandani M,
    2. Kong M,
    3. Tronstein E et al.
    Herpes simplex virus type 1 shedding in tears, and nasal and oral mucosa of healthy adults. Sex Transm Dis. 2016 Dec;43(12):756-60.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Lince KC,
    2. DeMario VK,
    3. Yang GT, et al.
    A systematic review of second-line treatments in antiviral resistant strains of HSV-1, HSV-2, and VZV. Cureus. 2023 Mar 9;15(3): e35958.
    OpenUrl
  15. 15.↵
    1. Schalkwijk HH,
    2. Snoeck R,
    3. Andrei G.
    Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives. Biochem Pharmacol. 2022 Dec;206: doi.org/10.1016/j.bcp.2022.115322.
  16. 16.↵
    1. Boes H,
    2. Goulioumis V,
    3. Wechsler A, et al.
    Clinical study on the effectiveness of three products in the treatment of herpes simplex labialis. Sci Rep. 2020 Apr;10(1):1-9.
    OpenUrlCrossRefPubMed
  17. 17.
    1. Singh BB,
    2. Udani J,
    3. Vinjamury SP et al.
    Safety and effectiveness of an L-lysine, zinc, and herbal-based product on the treatment of facial and circumoral herpes. Altern Med Rev. 2005 Jun;10(2):123-27.
    OpenUrlPubMed
  18. 18.
    1. Silva-Alvarez AF,
    2. de Carvalho AC,
    3. Benassi-Zanqueta É et al.
    Herpes labialis: A new possibility for topical treatment with well-elucidated drugs. J Pharm Sci. 2021 Oct;110(10):3450-56.
    OpenUrl
  19. 19.↵
    1. Ramalho KM,
    2. Cunha SR,
    3. Gonçalves F, et al.
    Photodynamic therapy and acyclovir in the treatment of recurrent herpes labialis: A controlled randomized clinical trial. Photodiagnosis Photodyn Ther. 2021 Mar;33:102093.
    OpenUrl
  20. 20.↵
    1. Cernik C,
    2. Gallina K,
    3. Brodell RT.
    The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med Res. 2008 Jun;168(11):1137-44.
    OpenUrl
  21. 21.↵
    1. Hull C,
    2. McKeough M,
    3. Sebastian K et al.
    Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. J Eur Acad Dermatol Venereol. 2009 Mar;23(3):263-67.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Spruance SL,
    2. McKeough MB.
    Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study. J Infect Dis. 2000 Jun;181(6):1906-10.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Hobbs MR,
    2. Jones BB,
    3. Otterud BE et al.
    Identification of a herpes simplex labialis susceptibility region on human chromosome 21. J Infect Dis. 2008 Feb 1;197(3):340-46.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Sauerbrei A.
    Bactericidal and virucidal activity of ethanol and povidone-iodine. MicrobiologyOpen. 2020 Sep;9(9):1-27.
    OpenUrlCrossRef
  25. 25.↵
    1. German Association for Applied Hygiene (VAH)
    . As a biocidal active substance, ethanol is indispensable for hygienic hand disinfection [Internet]. Bonn: Institut für Hygiene und Öffentliche Gesundheit der Universität Bonn; 2020 [cited 2023 Nov 8]. Available from: https://vah-online.de/files/download/vah-mitteilungen/VAH_Ethanol_biocide_29Oct2020_2.pdf
  26. 26.↵
    1. Centers for Disease Control and Prevention
    . Chemical disinfectants: Guideline for disinfection and sterilization in healthcare facilities [Internet]. Atlanta: Centers for Disease Control and Prevention; 2008 [cited 2023 Nov 8]. Available from: https://www.cdc.gov/infectioncontrol/guidelines/disinfection/disinfection-methods/chemical.html
  27. 27.↵
    1. Ferraz MG,
    2. Quaresma MR,
    3. Aquino LR, et al.
    Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol. 1990 Aug; 17(8):1022-24.
    OpenUrlPubMedWeb of Science
  28. 28.↵
    1. Gallagher EJ,
    2. Bijur PE,
    3. Latimer C, et al.
    Reliability and validity of a visual analog scale for acute abdominal pain in the ED. Am J Emerg Med. 2002 Jul; 20(4): 287-90.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Gayatri D,
    2. Efremov L,
    3. Mikolajczyk R, et al.
    Quality of life assessment and pain severity in breast cancer patients prior to palliative oncology treatment in Indonesia: A cross-sectional study. Patient Prefer Adherence. 2021 Sep;15: 2017-26.
    OpenUrl
  30. 30.↵
    1. Downie WW,
    2. Leatham PA,
    3. Rhind VM, et al.
    Studies with pain rating scales. Ann Rheum Dis. 1978 Aug; 37(4):378-81.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Lancaster GA,
    2. Thabane L.
    Guidelines for reporting non-randomized pilot and feasibility studies. Pilot Feasibility Stud. 2019 Dec;5(1):1-6.
    OpenUrl
  32. 32.↵
    1. Baker D,
    2. Eisen D.
    Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. Cutis. 2003 Mar;71(3):239-42.
    OpenUrl
  33. 33.↵
    1. Gürbüz MC,
    2. Kirtak N,
    3. Özyurtseven BT.
    Comparison of topical acyclovir and penciclovir in recurrent herpes labialis treatment. Cukurova Med J. 2021 Sep;46(3):927-33.
    OpenUrl
  34. 34.↵
    1. Slotosch CM,
    2. Kampf G,
    3. Löffler H.
    Effects of disinfectants and detergents on skin irritation. Dermatitis. 2007 Oct;57(4):235-241.
    OpenUrl
  35. 35.↵
    1. Carver CS,
    2. Scheier, MF,
    3. Segerstrom, SC.
    Optimism. Clin Psychol Rev. 2010 Nov;30(7):879-89.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.
    1. Carver CS,
    2. Scheier MF.
    On the self-regulation of behavior. Cambridge (UK): Cambridge University Press; 1998. 460 p.
  37. 37.↵
    1. Nsamenang SA,
    2. Hirsch JK.
    Positive psychological determinants of treatment adherence among primary care patients. Prim Health Care Res Dev. 2015 Jul;16(4):398-406.
    OpenUrl
  38. 38.↵
    1. Faulkner S,
    2. Smith A.
    A prospective diary study of the role of psychological stress and negative mood in the recurrence of herpes simplex virus (HSV1). Stress Health. 2009 Apr;25(2):179-87.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Herpes Simplex Virus-1 and Hand Sanitizer: A pilot study
Amanda L. Gibbs, Leciel K. Bono, JoAnn R. Gurenlian
American Dental Hygienists' Association Aug 2024, 98 (4) 28-36;
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords